To observe the effect of Fufang Jisheng Liujin Gao （复方寄生流浸膏 Compound Mistletoe Fluidextract） on blood pressure in the spontaneous hypertensive rats （SHR） and the renal hypertensive dogs （RHD）. Methods： T...To observe the effect of Fufang Jisheng Liujin Gao （复方寄生流浸膏 Compound Mistletoe Fluidextract） on blood pressure in the spontaneous hypertensive rats （SHR） and the renal hypertensive dogs （RHD）. Methods： The blood pressure-decreasing effects of single administration and 14-day consecutive administration of Compound Mistletoe Fluidextract （CMF） in SHR and RHD were investigated and compared with that of Niuhuang Jiangya Wan （牛黄降压丸 Bezoar Hypertension-relieving Pills）. Results： Both single administration and 14-day consecutive administration of CMF had significant hypotensive effects in SHR and RHD. Conclusion： The hypotensive action of CMF is gradual, but lasts for a longer period, with a dose-effect relationship in a range of doses.展开更多
To explore the feasibility of the full automatic animal experimental cabin to establish the animal models in normobaric/hypobaric hypoxic and high carbon dioxide environment. Methods： Sixty SPF-class male DS rats wer...To explore the feasibility of the full automatic animal experimental cabin to establish the animal models in normobaric/hypobaric hypoxic and high carbon dioxide environment. Methods： Sixty SPF-class male DS rats were divided into 2 groups, 20 for normobaric, hypoxic conditions and the other 40 for hypobaric, hypoxic conditions. For each group, the pulmonary arterial pressure and carotid arterial pressure indicators of rats were examined by using the physiological multi-detector, and the pulmonary vascular changes in the structure were observed. Results： The normobaric/hypobaric hypoxic with high carbon dioxide environment can promote the formation of pulmonary hypertension and accelerate changes in pulmonary vascular remodeling, and promote the right ventricular hypertrophy. Conclusion： Clinical applications showed that the animal experimental cabin has observed and controlled accurately. The result was safe, reliable and reproducible. The cabin can successfully establish the pulmonary hypertension model in normobaric/hypobaric hypoxic with high carbon dioxide environment, and in order to study the physiological mechanism of a variety of circulation and respiratory diseases caused by lack of oxygen, which provided an experimental technology platform for clinical research.展开更多
Objective： To explore the feasibility of the full automatic animal experimental cabin to establish the animal models in normobaric/hypobarie hypoxic and high carbon dioxide environment. Methods： 60 SPF-class male SD...Objective： To explore the feasibility of the full automatic animal experimental cabin to establish the animal models in normobaric/hypobarie hypoxic and high carbon dioxide environment. Methods： 60 SPF-class male SD rats were divided into two groups, 20 for normobaric, hypoxie conditions and the other 40 for hypobarie, hypoxic conditions. For each group, we examined the pulmonary arterial pressure and carotid arterial pressure indicators of rats by using the physiological muhi-detector measurement, and observed the pulmonary vascular changes in the structure. Results： The normobaric/hypobarie hypoxic with high carbon dioxide environment can promote the formation of pulmonary hypertension and accelerate changes in pulmonary vascular remodeling, and promote the right ventricular hypertrophy. Conclusion： Clinical applications showed that the animal experimental cabin has observed and controlled accurately. The result was safe, reliable and reproducible. The cabin can successfully establish the pulmonary hypertension model in normobaric/hypobaric hypoxie with high carbon dioxide enviromnent, and in order to study the physiological mechanism of a variety of circulation and respiratory diseases caused by lack of oxygen, which provided an experimental technology platform tor clinical research.展开更多
The management of portal hypertension has long been challenged by the limitations of invasive diagnostic methods.While hepatic venous pressure gradient(HVPG)measurement remains the gold standard for diagnosing clinica...The management of portal hypertension has long been challenged by the limitations of invasive diagnostic methods.While hepatic venous pressure gradient(HVPG)measurement remains the gold standard for diagnosing clinically significant portal hypertension(CSPH),its invasiveness and limited availability have necessitated the development of reliable,non-invasive alternatives(1,2).This need is particularly pressing given that CSPH represents a critical milestone in chronic liver disease progression,marking the threshold beyond which patients face increased risks of variceal bleeding and hepatic decompensation.展开更多
文摘To observe the effect of Fufang Jisheng Liujin Gao （复方寄生流浸膏 Compound Mistletoe Fluidextract） on blood pressure in the spontaneous hypertensive rats （SHR） and the renal hypertensive dogs （RHD）. Methods： The blood pressure-decreasing effects of single administration and 14-day consecutive administration of Compound Mistletoe Fluidextract （CMF） in SHR and RHD were investigated and compared with that of Niuhuang Jiangya Wan （牛黄降压丸 Bezoar Hypertension-relieving Pills）. Results： Both single administration and 14-day consecutive administration of CMF had significant hypotensive effects in SHR and RHD. Conclusion： The hypotensive action of CMF is gradual, but lasts for a longer period, with a dose-effect relationship in a range of doses.
文摘To explore the feasibility of the full automatic animal experimental cabin to establish the animal models in normobaric/hypobaric hypoxic and high carbon dioxide environment. Methods： Sixty SPF-class male DS rats were divided into 2 groups, 20 for normobaric, hypoxic conditions and the other 40 for hypobaric, hypoxic conditions. For each group, the pulmonary arterial pressure and carotid arterial pressure indicators of rats were examined by using the physiological multi-detector, and the pulmonary vascular changes in the structure were observed. Results： The normobaric/hypobaric hypoxic with high carbon dioxide environment can promote the formation of pulmonary hypertension and accelerate changes in pulmonary vascular remodeling, and promote the right ventricular hypertrophy. Conclusion： Clinical applications showed that the animal experimental cabin has observed and controlled accurately. The result was safe, reliable and reproducible. The cabin can successfully establish the pulmonary hypertension model in normobaric/hypobaric hypoxic with high carbon dioxide environment, and in order to study the physiological mechanism of a variety of circulation and respiratory diseases caused by lack of oxygen, which provided an experimental technology platform for clinical research.
文摘Objective： To explore the feasibility of the full automatic animal experimental cabin to establish the animal models in normobaric/hypobarie hypoxic and high carbon dioxide environment. Methods： 60 SPF-class male SD rats were divided into two groups, 20 for normobaric, hypoxie conditions and the other 40 for hypobarie, hypoxic conditions. For each group, we examined the pulmonary arterial pressure and carotid arterial pressure indicators of rats by using the physiological muhi-detector measurement, and observed the pulmonary vascular changes in the structure. Results： The normobaric/hypobarie hypoxic with high carbon dioxide environment can promote the formation of pulmonary hypertension and accelerate changes in pulmonary vascular remodeling, and promote the right ventricular hypertrophy. Conclusion： Clinical applications showed that the animal experimental cabin has observed and controlled accurately. The result was safe, reliable and reproducible. The cabin can successfully establish the pulmonary hypertension model in normobaric/hypobaric hypoxie with high carbon dioxide enviromnent, and in order to study the physiological mechanism of a variety of circulation and respiratory diseases caused by lack of oxygen, which provided an experimental technology platform tor clinical research.
基金supported by the Soonchunhyang University Research Fund.
文摘The management of portal hypertension has long been challenged by the limitations of invasive diagnostic methods.While hepatic venous pressure gradient(HVPG)measurement remains the gold standard for diagnosing clinically significant portal hypertension(CSPH),its invasiveness and limited availability have necessitated the development of reliable,non-invasive alternatives(1,2).This need is particularly pressing given that CSPH represents a critical milestone in chronic liver disease progression,marking the threshold beyond which patients face increased risks of variceal bleeding and hepatic decompensation.
